Trial intelligence / Profile preview

ARCC: Cilostazol for Aspirin Resistance in Chronic Stroke

NCT00446641Phase 4Completed

Sponsor
Asan Medical Center
Start
Mar 2007
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cilostazol in ischemic stroke, sponsored by Asan Medical Center. Started Mar 2007; status: completed.

02

Drugs

cilostazol
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT00446641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00446641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call